The most active biotech startup investors
426 investors hold three or more biotech startups each, 2,443 portfolio startups in all. The most active here are Y Combinator (112), RA Capital Management (96) and Plug and Play (85). 73 of them are accelerators.
Investors by their portfolio companiesRebuilt 6 Nov 2026
investors
426
portfolio startups
2,443
of them raised in 12 months
15
accelerators
73
Investors backing startups worldwide
| Investor | Startups here | Portfolio rounds, 12 mo | Latest activity |
|---|---|---|---|
 Y CombinatorAccelerator · United States · Terraferma, Tamarind Bio, Quinn | 112 | 255 | Oct 2026 |
 RA Capital ManagementInvestor · United States · Sanofi, BioMarin Pharmaceutical Inc., Moderna | 96 | 31 | Oct 2026 |
 Plug and PlayAccelerator · United States · Pauling, Blazar, Resilience | 85 | 154 | Nov 2026 |
 SOSVAccelerator · United States · Primarybioscience, Tidal Vision, Ginkgo Bioworks | 84 | 35 | Oct 2026 |
 OrbiMedVenture capital · United States · Velsera, Intellia Therapeutics, Angitia Biopharmaceuticals | 65 | 19 | Oct 2026 |
 ARCH Venture PartnersVenture capital · United States · GRAIL, Illumina, eGenesis | 64 | 17 | Oct 2026 |
 GVVenture capital · United States · GRAIL, Freenome, Dyno Therapeutics | 58 | 57 | Oct 2026 |
 Sofinnova PartnersVenture capital · France · IMIO, Ironwoodpharma, Verley Food | 48 | 14 | Oct 2026 |
 Foresite CapitalVenture capital · United States · Xaira Therapeutics, Tessera Therapeutics, Parabilis Medicines | 48 | 9 | Oct 2026 |
 High-Tech GründerfondsAccelerator · Germany · Zoetis, 3D Systems, Qnami | 46 | 47 | Nov 2026 |
 TechstarsAccelerator · United States · Certa.ai, Fermenstation, Metabologenomics | 44 | 97 | Oct 2026 |
| HHelmholtzAccelerator · Germany · Cytiva, Tcelltech, BioRN | 38 | 9 | Oct 2026 |
 Qiming Venture PartnersVenture capital · China · Agilent Technologies, Insilico, Schrodinger | 37 | 25 | Oct 2026 |
 F-Prime CapitalVenture capital · United States · Arexera Therapeutics, Insilico, Elucidata | 37 | 15 | Oct 2026 |
 DCVCVenture capital · United States · Freenome, Orca Bio, Frontiermeds | 35 | 27 | Sep 2026 |
 NEAVenture capital · United States · Sanofi, Labcorp, GSK | 34 | 38 | Oct 2026 |
 Ampersand Capital PartnersPrivate equity · United States · Charles River Laboratories, Clario, Revvity | 34 | – | – |
 Andreessen HorowitzVenture capital · United States · Freenome, Dyno Therapeutics, Asimov | 32 | 102 | Nov 2026 |
 Omega FundsVenture capital · United States · Merck & Co., Editas Medicine, Evotec | 32 | 4 | Feb 2026 |
 Wellington ManagementInvestor · United States · Moderna, Angitia Biopharmaceuticals, Oxford Nanopore Technologies | 30 | 10 | Sep 2026 |
 StartLifeAccelerator · Netherlands · Michroma, Allozymes, Ironic Biotech | 29 | 12 | Sep 2026 |
 Meta PlanetVenture capital · Estonia · 3D Systems, Opentrons, PostEra | 28 | 22 | Oct 2026 |
 Horizons VenturesVenture capital · Hong Kong · Cortical Labs, Deepcell, Chemify | 26 | 11 | Aug 2026 |
 Atinum InvestmentVenture capital · South Korea · Outpacebio, Valo Health, Sovargen | 26 | 7 | Sep 2026 |
 Nextech InvestVenture capital · Switzerland · Tango Therapeutics, Zymeworks, Arvinas | 26 | 2 | Oct 2026 |
 M VenturesVenture capital · Netherlands · Iktos, Neurable, Formo | 25 | 13 | Oct 2026 |
 EcoR1 CapitalVenture capital · United States · Freenome, Intellia Therapeutics, Bridgebio | 24 | 4 | Jun 2026 |
 Entrepreneur FirstAccelerator · United Kingdom · Blazar, Automata, immunitoAI | 23 | 58 | Oct 2026 |
| IIllumina VenturesVenture capital · Iambic Therapeutics, OraSure.com. Please be aware that OraSure Technologies, Inc., Integrated Biosciences | 23 | 7 | Oct 2026 |
 Aisling CapitalVenture capital · United States · Merck & Co., Bridgebio, Forge Biologics | 23 | 4 | Oct 2026 |
 LAVVenture capital · China · Merck & Co., Agilent Technologies, Legend Biotech | 23 | 2 | Feb 2026 |
 Max Planck InnovationAccelerator · Germany · MorphoSys, ALACRIS Theranostics, Proteros | 23 | 1 | Jul 2026 |
 Future Planet CapitalVenture capital · United Kingdom · Tropic, twig, Nuclera | 22 | 39 | Sep 2026 |
 Atlas VentureVenture capital · United States · MorphoSys, Intellia Therapeutics, Korro Bio | 22 | 4 | Jun 2026 |
 PontifaxVenture capital · Israel · Agomab Therapeutics, Kite Pharma, Eye-yon | 21 | 4 | Aug 2026 |
 Flagship PioneeringVenture capital · United States · Valo Health, ProFound Therapeutics, Moderna | 21 | – | – |
 General CatalystVenture capital · United States · Waypoint Bio, Resilience, Tahoe Therapeutics | 20 | 121 | Nov 2026 |
 Insight PartnersVenture capital · United States · Chemify, BrightInsight, Optimized Clinical Development | 20 | 83 | Oct 2026 |
 SFC CapitalVenture capital · United Kingdom · MetalloBio, Northern Gritstone, FourJaw | 20 | 81 | Oct 2026 |
| CCambridge EnterpriseAccelerator · United Kingdom · COLORIFIX, Pretzel Therapeutics, bit.bio | 20 | 28 | Sep 2026 |
The most backed startups worldwide
Recursion Pharmaceuticals
Insilico
Parabilis Medicines
AOA DX
Freenome
Chroma Bio, Inc.
Catalym
BioAge Labs
Xaira Therapeutics
Odyssey
Automata
Pretzel Therapeutics
BillionToOne
C16 Biosciences
DayOneBioRaising a round?
Tell us about your startup once: Alion matches it to the investors that back companies like it and tells you when a fund starts backing startups in .
Questions
Who invests in biotech startups?
426 investors hold three or more biotech startups each, 2,443 portfolio startups in all. The most active here are Y Combinator (112), RA Capital Management (96) and Plug and Play (85). 73 of them are accelerators.
How is this list built?
From what each investor holds: the portfolio page it publishes, the Y Combinator directory and the announced rounds that name it. An investor counts for a sector when at least three of its portfolio companies are based there; the list is rebuilt every night from 2,414 portfolios.
Source: investors' portfolio pages and announced rounds, 2,414 portfoliosUpdated 6 Nov 2026MethodologyJSONCC BY-SA 4.0